Octapharma AG - Company Profile
Powered by
All the data and insights you need on Octapharma AG in one report.
- Save hours of research time and resources with
our up-to-date Octapharma AG Strategy Report
- Understand Octapharma AG position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Octapharma AG (Octapharma) is a human protein product manufacturer that focuses on developing and producing medicines through human proteins from human plasma and cell lines. The company treats patients worldwide with products across immunotherapy, hematology, and critical care therapeutic areas. It sources plasma from company-owned plasma donation centers and other external sources. Octapharma owns plasma donation centers in the US and Germany and owns production facilities in Austria, Germany, France, Mexico, and Sweden. It’s production plants carry out plasma fractionation and purification, pharmaceutical production, research and development, product labeling, packaging, storage, and distribution. Octapharma is headquartered in Lachen, Switzerland.
Octapharma AG premium industry data and analytics
Products and Services
Products | Services | Brands |
---|---|---|
Human Protein | Plasma-Based Services | - |
Hematology | Support for Self-Sufficiency Partners | Albuminativ |
Immunotherapy | Albunorm | |
XYZ | XYZ | |
XYZ | XYZ | |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Regulatory Approval | In February, the company submitted a Biologics License Application Suppliment to the FDA, to expand the approval for wilate. |
2023 | Regulatory Approval | In February, the company announced the approval of Lyphilised S/D treated plasma octaplasLG for pre-hospital transfusion by European Authorities. |
2022 | Contracts/Agreements | In April, the company has partnered with the local authorities to provide furnished accommodation to Ukraine refugees. |
Competitor Comparison
Key Parameters | Octapharma AG | Abeona Therapeutics Inc | Liminal BioSciences Inc | China Biologic Products Holdings Inc | Grifols USA LLC |
---|---|---|---|---|---|
Headquarters | Switzerland | United States of America | Canada | China | United States of America |
City | Lachen | Cleveland | Belleville | Beijing | Los Angeles |
State/Province | Schwyz | Ohio | Ontario | Beijing | California |
No. of Employees | 11,573 | 84 | 43 | 2,269 | - |
Entity Type | Private | Public | Private | Private | Private |
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Wolfgang Marguerre | Chairman; Chief Executive Officer | Executive Board | - | - |
Roger Machler | Chief Financial Officer | Senior Management | - | - |
Olivier Clairotte | Chief Production Officer | Senior Management | - | - |
Wolfgang Frenzel | Head - Research and Development | Senior Management | - | - |
Flemming Nielsen | President - Octapharma USA Inc | Senior Management | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward